BAX
Baxter International · Health Care
8.3%
typical move (median |reaction| of last 8)
2026-10-29 pre · likely
next expected · estimated from pattern
13
scored events
Last eight reactions
2025-02-03 → 2026-07-30
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-07-30 | pre | +8.1% | 8.1% | -2.8% | -7.1% |
| 2026-04-30 | pre | +4.0% | 4.0% | -2.2% | +1.7% |
| 2026-02-12 | pre | -16.1% | 16.1% | +14.3% | -4.1% |
| 2025-10-30 | pre | -14.4% | 14.4% | -4.7% | -2.7% |
| 2025-07-31 | pre | -22.4% | 22.4% | +8.0% | +9.4% |
| 2025-05-01 | pre | -1.7% | 1.7% | +0.7% | -5.5% |
| 2025-02-20 | pre | +8.5% | 8.5% | +9.2% | +7.8% |
| 2025-02-03 | pre | -2.8% | 2.8% | -3.8% | +14.0% |
Source filings
2026-07-30 · 8-K press release
BAXTER REPORTS SECOND-QUARTER 2026 RESULTS • Second-quarter sales of $2.96 billion increased 5% on both a reported and organic basis, 1,2 reflecting growth in all segments and divisions • Second-quart
2026-04-30 · 8-K press release
BAXTER REPORTS FIRST-QUARTER 2026 RESULTS • Sales from continuing operations of $2.7 billion increased 3% on a reported basis and declined 1% on an organic basis 1,2 • U.S. GAAP 3 diluted earnings per
2026-02-12 · 8-K press release
BAXTER REPORTS FOURTH-QUARTER 2025 RESULTS • Fourth-quarter sales from continuing operations of $2.97 billion increased 8% on a reported basis and 3% on an operational basis 1,2 • Fourth-quarter U.S.
2025-10-30 · 8-K press release
BAXTER REPORTS THIRD-QUARTER 2025 RESULTS • Third-quarter sales from continuing operations of $2.84 billion increased 5% on a reported basis and 2% on an operational basis 1,2 • Third-quarter U.S. GAA
2025-07-31 · 8-K press release
BAXTER REPORTS SECOND-QUARTER 2025 RESULTS • Second-quarter sales from continuing operations of $2.81 billion increased 4% on a reported basis and 1% on an operational basis, in line with the company’
2025-05-01 · 8-K press release
BAXTER REPORTS FIRST-QUARTER 2025 RESULTS • First-quarter sales from continuing operations of $2.63 billion increased 5% on both a reported and operational basis, exceeding the company’s previously is
2025-02-20 · 8-K press release
BAXTER REPORTS FOURTH-QUARTER AND FULL-YEAR 2024 RESULTS • Fourth-quarter sales from continuing operations of $2.75 billion increased 1% on a reported basis and 2% on a constant currency basis, exceed
2025-02-03 · 8-K press release
BAXTER ANNOUNCES CEO RETIREMENT AND APPOINTMENT OF COO • José (Joe) E. Almeida to retire as Chair, President and Chief Executive Officer • Lead Independent Director Brent Shafer appointed Chair and In